Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

Clinical trial NCT06975514 · COMPLETED

Trial details

NCT number: NCT06975514
Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Disorder

Start date: 2025-03-25
Primary completion: 2025-07-21
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.